Efficacy and safety of lorlatinib in patients with ALK- and ROS1-rearranged metastatic non-small cell lung cancer treated within the compassionate use program in Spain
Titel:
Efficacy and safety of lorlatinib in patients with ALK- and ROS1-rearranged metastatic non-small cell lung cancer treated within the compassionate use program in Spain
Auteur:
Calles, Antonio Alonso, Mirian Martín-Martorell, Paloma Gómez, Ana de Castro, Javier Martínez-Aguillo, Maite Estival, Anna Mosquera, Joaquin Martínez-Banaclocha, Natividad Majem, Margarita Reyes, Roxana Azkona, Eider Ortega, Ana Laura Aguin, Santiago Santos, Ana Aguilar, Andrés Cucurull, Marc Blasco, Ana Calvo, Virginia Isla, Dolores Nadal, Ernest Aguado, Carlos Sais, Elia Juan-Vidal, Oscar Diz-Taín, MPilar Taus, Álvaro Villanueva, Noemí Bayona, Cristina Amenedo, Margarita Mielgo, Xabier Arriola, Esperanza Baena, Javier